Activity trends of the largest Russian pharmaceutical wholesalers
Information agency Credinform represents an overview of activity trends of the largest Russian pharmaceutical wholesalers.
Trading companies with the largest volume of annual revenue (TOP-10 and TOP-1000) were selected for the analysis, according to the data from the Statistical Register for the latest available periods (for 2015 – 2017). The analysis was made on the basis of the data of the Information and Analytical system Globas.
The largest company in terms of net assets is OTCPHARM NJSC. In 2018, its net assets amounted to more than 51,4 billion rubles.
The smallest amount of net assets in the TOP-1000 list was hold by NJSC ROSTA. The insufficiency of property of this company in 2017 was expressed as a negative value of -13,5 billion rubles.
The average values of net assets tend to increase over the ten-year period (Picture 1).
The shares of TOP-1000 enterprises with insufficiency of assets have a tendency to decrease in the last five years (Picture 2).
The revenue volume of 10 leading companies of the industry made 35% of the total revenue of TOP-1000 in 2017 (Picture 3). It points to a relatively high level of competition in the industry.
In general, there is a decrease in industry average revenue over the ten-year period (Picture 4).
Profit and loss
The largest company in terms of net profit value is JSC PHARMSTANDARD. The company's profit amounted to more than 45,5 billion rubles for 2018.
Industry average values of net profit trend to increase over the past ten years (Picture 5).
Average values of net profit’s indicators of TOP-1000 companies increase for the five-year period, at the same time the average value of net loss increases significantly. (Picture 6).
Key financial ratios
Over the ten-year period the average indicators of the total liquidity ratio of TOP-1000 enterprises were in the range of recommended values - from 1,0 up to 2,0, with a tendency to increase (Picture 7).
The average industry values of the return on investment ratio were mainly at a relatively high level with the tendency to increase over the course of ten years (Picture 8).
This ratio of business activity showed a tendency to decrease over the ten-year period (Picture 9).
66% of TOP-1000 companies are registered in the Register of small and medium-sized enterprises of the Federal Tax Service of the RF. At the same time, their share in the total revenue amounted to 14,5% in 2017, that is significantly lower than the national average (Picture 10).
Main regions of activity
The TOP-1000 companies are distributed highly unequal across Russia and registered in 69 regions. Almost 69% of their revenues are concentrated in Moscow and Moscow region (Picture 11).
Financial position score
An assessment of the financial position of TOP-1000 companies shows that the financial position of most of them is above average (Picture 12).
Solvency index Globas
The vast majority of TOP-1000 companies got Superior/High or Strong/Medium Solvency index Globas, that points to their ability to pay off their debts in time and fully (Picture 13).
A comprehensive assessment of activity of pharmaceutical wholesalers, taking into account the main indices, financial indicators and ratios, points to the prevalence of positive trends in the industry (Table 1).
|Trends and evaluation factors||Specific share of factor, %|
|Rate of growth (decline) in the average size of net assets||10|
|Increase / decrease in the share of enterprises with negative values of net assets||10|
|Level of competition||5|
|Rate of growth (decline) in the average size of revenue||-10|
|Rate of growth (decline) in the average size of profit (loss)||10|
|Growth / decline in average values of net profit of TOP-1000 companies||10|
|Growth / decline in average values of net loss of TOP-1000 companies||-10|
|Increase / decrease in average values of total liquidity ratio||10|
|Increase / decrease in average values of return on investment ratio||10|
|Increase / decrease in average values of asset turnover ratio||-10|
|Share of small and medium-sized enterprises in the industry in terms of revenue being more than 22%||-10|
|Financial position (the largest share)||10|
|Solvency index Globas (the largest share)||10|
|Average value of factors||2,5|
positive trend (factor), negative trend (factor).